Keyphrases
Tolerability
100%
Antipsychotics
100%
Network Meta-analysis
100%
Clozapine
100%
Treatment-resistant Schizophrenia
100%
Olanzapine
50%
Schizophrenia
25%
Quality of Life
12%
MEDLINE
12%
Randomized Controlled Trial
12%
Adverse Events
12%
Sensitivity Analysis
12%
Second Best
12%
Adverse Effects
12%
Weight Gain
12%
Treatment Resistance
12%
Potential Alternatives
12%
Subgroup Analysis
12%
Response to Treatment
12%
Sedation
12%
Cochrane
12%
Blinded Study
12%
Risperidone
12%
Haloperidol
12%
Efficacy Outcomes
12%
Quetiapine
12%
Positive Psychotic Symptoms
12%
Open Science Framework
12%
Sertindole
12%
Negative Symptoms of Schizophrenia
12%
Other-efficacy
12%
Chlorpromazine
12%
Fluphenazine
12%
Treatment-related Symptoms
12%
Open Study
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Clozapine
100%
Treatment-Resistant Schizophrenia
100%
Olanzapine
50%
Randomized Controlled Trial
12%
Risperidone
12%
Sertindole
12%
Fluphenazine
12%
Side Effect
12%
Adverse Event
12%
Quetiapine
12%
Negative Syndrome
12%
Positive Syndrome
12%
Chlorpromazine
12%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
12%
Neuroscience
Clozapine
100%
Meta-Analysis
100%
Treatment-Resistant Schizophrenia
100%
Olanzapine
50%
Randomized Controlled Trial
12%
Adverse Effect
12%
Quetiapine
12%
Risperidone
12%
Chlorpromazine
12%
Sertindole
12%
Fluphenazine
12%
Negative Syndrome
12%
Positive Syndrome
12%
Haloperidol
12%